Showing 1 - 10 results of 10 for search 'Enrique M Ocio', query time: 0.02s
Refine Results
-
1
DRUGGABLE MM THERAPEUTICS: PATHOGENETIC PATHWAYS by Enrique M Ocio
Published 2022-04-01
Article -
2
-
3
RELAPSED/REFRACTORY MULTIPLE MYELOMA: THE CURRENT STATE OF PLAY by María-Victoria Mateos, Enrique M. Ocio, Verónica González, Julio Dávila
Published 2015-07-01
Article -
4
-
5
Drug-induced Thrombotic Microangiopathy During Maintenance Treatment in a Patient With Multiple Myeloma by Víctor Higuero Saavedra, Verónica González-Calle, Eduardo Sobejano, Josefa Sebastiá, Mónica Cabrero, Jose María Bastida, Noemi Puig, Enrique M. Ocio, María-Victoria Mateos
Published 2019-06-01
Article -
6
Phase 1b Study of Isatuximab in Combination With Bortezomib, Cyclophosphamide, and Dexamethasone in Newly Diagnosed, Transplant-ineligible Multiple Myeloma Patients by Enrique M. Ocio, Sara Bringhen, Joaquin Martinez-Lopez, Jesus San-Miguel, Stefania Oliva, Paula Rodriguez-Otero, Nadia Le Roux, Yvonne Dong, Severine Doroumian, Sandrine Macé, Maria-Victoria Mateos
Published 2023-02-01
Article -
7
Protein Translation Inhibition is Involved in the Activity of the Pan-PIM Kinase Inhibitor PIM447 in Combination with Pomalidomide-Dexamethasone in Multiple Myeloma by Teresa Paíno, Lorena González-Méndez, Laura San-Segundo, Luis A. Corchete, Susana Hernández-García, Andrea Díaz-Tejedor, Esperanza M. Algarín, Pedro Mogollón, Montserrat Martín-Sánchez, Norma C. Gutiérrez, María-Victoria Mateos, Mercedes Garayoa, Enrique M. Ocio
Published 2020-09-01
Article -
8
Phase I study of plitidepsin in combination with bortezomib and dexamethasone in patients with relapsed/refractory multiple myeloma by María Victoria Mateos, Felipe Prosper, Jesús Martin Sánchez, Enrique M. Ocio, Albert Oriol, Cristina Motlló, Jean‐Marie Michot, Isidro Jarque, Rebeca Iglesias, María Solé, Sara Martínez, Carmen Kahatt, Salvador Fudio, Gema Corral, Ali Zeaiter, Lola Montilla, Vincent Ribrag
Published 2023-02-01
Article -
9
Stroma-Mediated Resistance to S63845 and Venetoclax through MCL-1 and BCL-2 Expression Changes Induced by miR-193b-3p and miR-21-5p Dysregulation in Multiple Myeloma by Esperanza M. Algarín, Dalia Quwaider, Francisco J. Campos-Laborie, Andrea Díaz-Tejedor, Pedro Mogollón, Elena Vuelta, Montserrat Martín-Sánchez, Laura San-Segundo, Lorena González-Méndez, Norma C. Gutiérrez, Ramón García-Sanz, Teresa Paíno, Javier De Las Rivas, Enrique M. Ocio, Mercedes Garayoa
Published 2021-03-01
Article -
10
Pembrolizumab as Consolidation Strategy in Patients with Multiple Myeloma: Results of the GEM-Pembresid Clinical Trial by Noemí Puig, Luis A. Corchete-Sánchez, José J. Pérez-Morán, Julio Dávila, Teresa Paíno, Javier de la Rubia, Albert Oriol, Jesús Martín-Sánchez, Felipe de Arriba, Joan Bladé, María-Jesús Blanchard, Verónica González-Calle, Ramón García-Sanz, Bruno Paiva, Juan-José Lahuerta, Jesús F. San-Miguel, María-Victoria Mateos, Enrique M. Ocio
Published 2020-12-01
Article